Exodus Point Capital Management, LP Solid Biosciences Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.74 - $1.79 $47,423 - $114,713	-64,086 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.69 - $2.46 $67,769 - $98,646	40,100 Added 167.18%	64,086 $112,000
Q3 2021 Nov 15, 2021	SELL	$2.38 - $3.77 $19,516 - $30,914	-8,200 Reduced 25.48%	23,986 $57,000
Q2 2021 Aug 16, 2021	BUY	$3.49 - $5.51 $30,984 - $48,917	8,878 Added 38.09%	32,186 $118,000
Q1 2021 May 17, 2021	SELL	$5.37 - $10.72 $121,222 - $241,993	-22,574 Reduced 49.2%	23,308 $129,000

Q4 2020 Feb 16, 2021	BUY	$3.08 - $7.79 $141,316 - $357,420	45,882 New	45,882 $348,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $44.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.